Cargando…

Focus on anticancer therapy-induced cardiotoxicity from the perspective of oncologists

Detalles Bibliográficos
Autores principales:	Liu, Binliang, Wang, Yanfeng, Lyu, Dan, Ma, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746743/ https://www.ncbi.nlm.nih.gov/pubmed/35916555 http://dx.doi.org/10.1097/CM9.0000000000002133

Ejemplares similares

Knowledge level of cardio-oncology in oncologist and cardiologist: a survey in China
por: Liu, Binliang, et al.
Publicado: (2023)

Proton beam therapy causing pericarditis – a rare case of radiation induced cardiotoxicity
por: Gupta, Rahul, et al.
Publicado: (2022)

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients
por: Li, Yiqun, et al.
Publicado: (2022)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Is Chat-GPT4 a qualified surgical oncologist?
por: Tang, Yaxiong, et al.
Publicado: (2023)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018)

New advances in medical imaging technology for the evaluation of anthracycline-induced cardiotoxicity
por: Su, Nan, et al.
Publicado: (2022)

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
por: Adhikari, Archana, et al.
Publicado: (2021)

In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors
por: Sabater, Sebastià, et al.
Publicado: (2021)

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
por: Heemelaar, Julius C., et al.
Publicado: (2022)

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
por: Peng, Kezheng, et al.
Publicado: (2023)

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020)

Burden on Oncologists When Communicating the Discontinuation of Anticancer Treatment
por: Otani, Hiroyuki, et al.
Publicado: (2011)

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014)

Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies
por: Montaigne, David, et al.
Publicado: (2012)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
por: Keung, Wendy, et al.
Publicado: (2021)

Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2019)

Towards evidence-based management of patients treated with cardiotoxic chemotherapy: A collaborative effort of cardiologists and oncologists
por: Leerink, J. M., et al.
Publicado: (2018)

Role of non-cardiomyocytes in anticancer drug-induced cardiotoxicity: A systematic review
por: Xie, Suifen, et al.
Publicado: (2022)

Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
por: Choksey, Anurag, et al.
Publicado: (2021)

Radiology reporting in oncology—oncologists’ perspective
por: Spînu-Popa, Elisabeta Valeria, et al.
Publicado: (2021)

Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
por: Tini, Giacomo, et al.
Publicado: (2023)

Two novel anticancer compounds with minimum cardiotoxic property
por: Afsharirad, Tayebeh, et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007)

Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity
por: Marslin, Gregory, et al.
Publicado: (2015)

microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
por: Henderson, John, et al.
Publicado: (2021)

Healthcare simulation in China: current status and perspectives
por: Li, Meng-Lin, et al.
Publicado: (2019)

Abscopal Effect, From Myth to Reality: From Radiation Oncologists' Perspective
por: Yilmaz, Melek Tugce, et al.
Publicado: (2019)

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
por: Xu, Yang, et al.
Publicado: (2011)

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)

Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
por: Pharoah, Blaze M., et al.
Publicado: (2023)

In Vivo Cardiotoxicity Induced by Sodium Aescinate in Zebrafish Larvae
por: Liang, Jinfeng, et al.
Publicado: (2016)

Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs
por: Kuriakose, Robin K., et al.
Publicado: (2016)

Cardiotoxicity due to targeted anticancer agents: a growing challenge
por: Shah, Chintan P., et al.
Publicado: (2019)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ucp65t7eavjfqki4gq7omm1mtb